Neuroimaging places in the hands of neurologists powerful tools for clinical diagnosis and patient management. In this program, attendees will have an opportunity to test and improve their knowledge of neuroimaging by learning an approach to neuroimaging studies, comparing their responses to those of other attendees when reviewing different neuroimaging cases, and reviewing carefully a set of difficult neuroimaging cases discussed by the faculty.

Completion Message:

Participants should be able to describe an organized approach to interpreting neuroimaging studies, as well as identify important imaging features of common and some less common disorders.

Dr. Dietrich has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Consultant agreement with Unum Therapeutics and Monteris Medical.

Joshua P. Klein, MD, PhD, FANA, FAAN

Dr. Klein has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with the American Academy of Neurology Institute, Best Doctors Inc., Advance Medical Inc., DocFlight Inc., and various law firms for serving as a medical expert. Dr. Klein has received personal compensation in an editorial capacity for McGraw Hill Publishers. Dr. Klein has received royalty, license fees, or contractual rights payments from McGraw Hill Publishers.

Joseph C. Masdeu, MD, PhD, FAAN

Dr. Masdeu has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GE NFL Medical Advisory Board. Dr. Masdeu has received research support from Acadia, Avanir, Abbvie, GE Health, Eli Lilly, Biogen, and Novartis.